Vancouver digital health startup Curatio has merged with Sydney, Australia’s RxMx to form RxPx.
Backed by Australian private equity firm Pemba Capital Partners, the two innovators join to support overburdened doctors and isolated patients with award-winning patient-first, digital-first technology.
The name RxPx combines Rx for prescription medication and Px for patient experience.
With a mission of No Patient Alone, RxPx provides an end-to-end workflow solution that reduces burden on doctors, and supports patients at scale.
The merger comes at a time when health systems are collapsing, pharmaceutical companies are undergoing massive change, and patients are increasingly relying on digital options.
RxMx was started by doctors for doctors to support physician workflows through automated processes that increase speed and access to therapy.
Co-founded by local entrepreneur Lynda Brown-Ganzert, Curatio was started by patients for patients as a social health prescription, enabling any healthcare organization to easily deliver private, personalized social support, education, daily coaching and adherence tracking.
Two years ago Curatio raised a Series A round led by Vancouver’s Rhino Ventures with participation from Conexus Venture Capital Fund.
The merger comes at a time when health systems are collapsing, pharmaceutical companies are undergoing massive change, and patients are increasingly relying on digital options.
“The need for a social health prescription is increasingly urgent and the level of physician burnout is a serious concern for the entire ecosystem,” says Brown-Ganzert regarding the merger. “Any healthcare organization can use the RxPx solution, and brand it for their program, therapy, clinic or membership.”
Both platforms have been a success with patients, with 94% of users still using RxMx one year later. In a Curatio case study where a pharmaceutical company was losing patients early due to a manageable side-effect, 92% of the users remained on therapy leveraging the peer-to-peer social network solution. Case studies for both companies have shown user adherence rates reaching 90%.
“We really are on a mission to transform lives. No patient should be alone and without support when dealing with a health challenge, and no doctor should be without the tools to easily and safely onboard their patient onto a new therapy or program,” says Brown-Ganzert.
“We’re simply two passionate teams of doctors, patients and digital experts that want to empower our customers and partners to deliver better healthcare for everyone.”
Leave a Reply